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Detecting Counterfeit Anti-malarials through Comparison between High Pressure
Liquid Chromatography and other Methods of Analysis

Abstract

Counterfeit pharmaceuticals are an increasing trend in the world of criminal
activity because the business of making fake pharmaceuticals is highly profitable. The
scientific community needs to develop clear-cut methods of detection for counterfeit
pharmaceuticals because this is an issue that affects human health and because the use
of prescription drugs is so prevalent. This study used high-pressure liquid
chromatography (HPLC) and fluorescence spectroscopy to produce qualitative and
quantitative data about quinine, mefloquine, and choloroquine. These were studied
because they are common anti-malarial drugs used in developing nations and they are
often counterfeited. Tablet mixtures meant to replicate pharmaceutical tablets were
prepared and analyzed using HPLC to have concentrations ranging from 11 to 62 ppm.
Fluorescence spectroscopy determined suitable emission and excitation wavelengths for
quinine and mefloquine to be 455 nm and 250 run respectively and 465 run and 365 nm
for chloroquine.
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Introduction
Counterfeit pharmaceuticals are an increasing trend in the world of criminal
activity. This mainly stems from the reality that the business of making fake
pharmaceuticals is highly profitable. 1 A counterfeit medication is defined by the World
Health Organization (WHO) as a drug that is intentionally labeled incorrectly which
means it could have an incorrect product name or source listed. This definition applies
to both brand and generic drugs. Counterfeited drugs may have the correct ingredients
but incorrect labeling, the wrong ingredients, low or no active ingredients. 2
Detecting fake pharmaceuticals in developed countries is easier than detecting
counterfeits in underdeveloped nations because more financial support and advanced
technology exists. In industrial nations, medications that are counterfeited often are
drugs that are used for comfort such as hormones and antihistamines. 3 The problem
with detection of fake pharmaceuticals in third world countries is that the most often
counterfeited drugs are those that treat life-threatening illnesses which include
antibiotics and anti-malarials. WHO cites that developing countries have the highest
percentages of drug counterfeits; in certain areas about 25 percent of drugs are fake and
in some areas as high as 50 percent of the drugs being used are counterfeit. 4 The
scientific community needs to develop clear-cut methods of detection for counterfeit
pharmaceuticals that technicians in developing countries can easily learn how to
operate.
The three active ingredients studied in this research were chloroquine,
mefloquine, and quinine because they are the most common active ingredients in anti
malarials.3 The structures of these active ingredients are shown in Figure 1. It is
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important to quantify the amount of active ingredient in the drug because many
counterfeits contain small amounts of the active ingredient in order to pass simple drug
quality checks that include color tests. 5
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Figure 1. Structure of chloroquine (A), quinine (8), and mefloquine (C).

The research focused on developing quick and simple methods for detecting
counterfeit anti-malarial drugs and quantifying the active ingredients. Ultraviolet
Visible (UV-Vis) spectroscopy was used to characterize the molecules on a spectrum in
order to identify peaks obtained from high-pressure liquid chromatography (HPLC).
UV-Vis spectroscopy produces infom1ation about how much incident light of a
particular wavelength is being absorbed by the sample. UV-Vis is useful for the
molecules being studied because quinine, mefloquine, and chloroquine have double
bonds within the cyclic structures of the molecules that absorb UV light.
Fluorescence spectroscopy was investigated as a less expensive and more
efficient method of detection. It works by exciting the molecules of the compound and
then detecting the amount of photons released after the molecules relax to ground state.
Fluorescence is useful with the molecules being researched because it works optimally
with molecules containing conjugated double bonds and structural rigidity. Structural
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rigidity enables the electrons to lose their energy to fluorescence and not to vibrational
or rotational relaxation.
HPLC works by using a pump to move a mobile phase and a mixture of analytes
along a stationary phase and a detector that determines the amount of time each analyte
takes to elute from the column. This project will focus on analyzing mixtures of the
active ingredient with common cutting ingredients such as silica, sucrose, talc, etc. 3
HPLC has been used to determine concentrations of chloroquine, mefloquine,
and quinine. In a study done by Gaudiano et al, compounded pills with varying
formulations with and without the active ingredient were created and analyzed using
HPLC. In the pills where active ingredient was present, it was detected at 98-102% of
the expected amount. Some of the inactive ingredients included those frequently used
by counterfeiters such as silica, sucrose, maize starch, and talc.3 Some counterfeiters
will even put pain relievers such as acetaminophen into the counterfeit medications to
make the patients think they are recovering from their illness. 1
HPLC is able to separate mixtures of molecules within one sample; this is
exceptionally useful for tablets that may contain only a small portion of the real active
ingredient and largely contains a false active ingredient. This instrument produces
chromatograms containing peaks that indicate when the sample eluted the column
which is also known as the retention time. Chromatograms are graphs that display
absorbance on the y-axis and time on the x-axis. This specific instrument has a multi
wavelength detector called a diode array detector (DAD). The DAD produces a
spectrum for each time point on the chromatogram. The ability to distinguish the
chromatogram peaks based on data about various wavelengths is important when the
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sample is a mixture of different molecules. For example, a sample with several
compounds that absorb at different wavelengths has to be analyzed only once because
the DAD detects data for a complete range of wavelengths. The type of HPLC used was
reversed-phase meaning the column is non-polar while the mobile phase is relatively
polar.
When choosing mobile phases, it is important to know whether the molecules of
interest are hydrophobic or hydrophilic because hydrophobic molecules will elute
quicker with an organic mobile phase while the hydrophilic molecules will elute with
an aqueous phase. Another way to vary the mobile phases and to have better peak
separation is by employing the use of a mobile phase gradient. Usually gradients begin
with a greater aqueous mobile phase percentage so that polar molecules will elute and
then as the gradient changes to a higher percentage of organic mobile phase, the less
polar molecules will begin to elute. If only one molecule of interest exists in the sample
then an isocratic gradient can be used in which only one mobile phase is used and is
made to suit the polarity of the molecule. Filtering all samples and any solvents used
that are not HPLC grade is important because the small column can easily be clogged.
A guard column can also be used to collect any particulate matter that would have
otherwise entered the column.
In order to assure reproducibility of the results between the sample runs, the
oven can be used so that the temperature can be set to remain the same during each run.
Increasing the temperature can also allow the samples to elute quicker. A diagram of a
typical HPLC is shown in Figure 3.
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Figure 3. This is a diagram illustrating the various parts of the HPLC. The solvent reservoir contains the
mobile phases. The degasser is a vacuum that pulls out any air bubbles to ensure better peak separation.
The detector for the particular HPLC used in this study was a multi-wavelength detector called a diode
array detector (DAD).

Scientists focused on this urgent crisis have employed both simple and
complicated methods to distinguish between real and fake pharmaceuticals. Some
simple methods include thin-layer chromatography (TLC) and colorimetry. TLC shows
a qualitative comparison between the active ingredient in the sample drug and a known
standard. Colorimetry is a reaction between the sample and a reagent to yield a color,
which is usually indicative of the amount of active ingredient. Although usually the
color is proportional to the concentration of the active ingredient, the results of
colorimetry tests are not quantitative because they are still based on a person's
subjective comparison to a color chart. A group of scientists led by Michael Green at
the Centers for Disease Control and Prevention in Atlanta, Georgia created a
colorimetric test for determining the quality of artesunate, an anti-malarial drug. The
test was based on the yellow color created when artesunate was mixed with a base, a
buffer and a reagent. 2 Another study was done to detect quinoline which is a structure
found within quinine, mefloquine and chloroquine. The structure is shown in Figure 2. 5
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Figure 2. Structure of quinoline which is found within mefloquine and chloroquine.

One problem with colorimetry tests is that these tests are easily passed by
counterfeiters. One such test for artesunate detected a free amine, which is a functional
group that contains nitrogen. When counterfeiters learned of this, they merely added a
free amine to the mixture and their drugs were able to pass the test. 4
This research project is meant to create a foundation of knowledge about
detecting the common anti-malarial active ingredients, chloroquine, mefloquine, and
quinine using simple and inexpensive tests. In order to ensure quantitative data, HPLC
will be used to determine specific concentrations. Qualitative ahd semi-quantitative
data were ascertained using fluorescence spectroscopy.
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Experimental

HPLC
All standards and samples were analyzed on a Shimadzu Prominence. A mobile
phase was made using 14 M H3PO4, phosphoric acid, and filtered DI water. The mobile
phase was 50 mM and had a pH of 1. 7. Stock solutions were made for quinine sulfate
dihydrate which was purchased from ACROS Organics, mefloquine phosphate which
was purchased from Spectrum Chemical and chloroquine hydrochloride which was
purchased from Spectrum Chemical. The drug was then dissolved in 25 mL of the
H3PO4 mobile phase which yielded a 1000 ppm solution. Mixture standards were made
and yielded standard concentrations were 1, 5, 10, 20 and 25 ppm. The second mobile
phase used was HPLC grade acetonitrile. The H 3PO4 was mobile phase A and the
acetonitrile was mobile phase B (mpB). The gradient was as follows: from 0-2 minutes,
mpB was held constant at 10%, from 2-10 minutes, the mpB changed from 10% to
90%, from 10-11 minutes, mpB was changed back to 10% and then from 11-15 minutes
it was held constant at 10%. The method included a sample injection of 10 µL and a
flow rate of 1 mL/min for the mobile phases. The standards were analyzed using HPLC
employing the method as just described.
Tablet mixtures were made to replicate the conditions of actual pharmaceutical
tablets. The amounts of active ingredients varied from the amount found in a real
prescription to lesser amounts. The active and inactive ingredients are listed in Table 1.
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Tablet A

Active Ingredient(s)
Quinine (324 mg)

Tablet B

Chloroquine (500 mg)

Tablet C

Mefloquine (90 mg)

Tablet D
Tablet E
Tablet F

None (Blank mixture)
Quinine (200 mg)
Chloroquine (300 mg)

Tablet G
TabletH
Tablet I

Aspirin (324 mg)
Acetarninoohen (324 mg)
Aspirin (224 mg), quinine (100 ml!)

Table 1. Amounts of active and inactive ingredients.

Inactive Irnrredients
Talc, magnesium stearate, com
starch
Polyethylene glycol, calcium
phosphate, cornstarch, magnesium
stearate
Lactose, magnesium stearate, talc,
cornstarch
Cornstarch, magnesium steaiate, talc
Cornstarch, magnesium stearate, talc
Polyethylene glycol, calcium
phosphate, cornstarch, magnesium
stearate
Talc, magnesium stearate, cornstarch
Talc, magnesium stearate, cornstarch
Talc, magnesium stearate, cornstarch

Tablets E and F were made to emulate counterfeit drugs that had decreased amounts of
the active ingredient. Tablet G and H were made to imitate a quinine tablet but these
tablets had a different active ingredient, either aspirin or acetaminophen. The lactose,
polyethylene glycol, potassium phosphate, calcium phosphate and talc were all
purchased from Fisher Scientific Company. The cornstarch was purchased from Wal
mart and was Great Value brand. The magnesium stearate was purchased from MP
Biomedicals, LLC. The quinine sulfate dihydrate was purchased from ACROS
organics. Amounts of these tablet mixtures ranging from 10 to 20 mg were diluted
using the H3PO4 mobile phase to detectable concentrations of active ingredients that
ranged from Oto 12.5 ppm. The solutions were placed in an ultrasonic bath for 5
minutes to ensure that all soluble particles were dissolved. Each solution was then
filtered using 0.45 µm nylon filters to clear any particulate matter and then analyzed
using HPLC.
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Fluorescence
Each stock solution was analyzed using the Cary Eclipse Fluorescence
Spectrophotometer. Several solvents were made and used for this part ofthe research.
A 50 mM potassium phosphate, KH2PO4 buffer was made and used initially.
Concentrated phosphoric acid, H3PO4, was added to the solution in order to lower the
pH and yield a buffer solution that had a pH of2.9. Sulfuric acid, 50 mM H2 SO4, with a
pH of1.2 was also used as a solvent to determine the effect ofpH on fluorescence
intensity. The mobile phase ofH3PO4, which had a pH of1.8, was also used to test the
effects ofthe phosphate ion. Standards were prepared for each active ingredient
consisting ofthe following concentrations: 0.0001, 0.001, 0.01, 0.1, and 1.

UV-Vis
Solutions ofthe drugs were analyzed on an Agilent UV-Vis 8453. All three
1000 ppm stock solutions of each drug were diluted using the mobile phase, 50 rnM
H3PO4, in a 1: 10 ratio.

TLC
Several TLC methods were attempted during this research using Whatrnan
4410-222 TLC plates PE SIL G/UV254 with flexible polyester backing. All three stock
solutions were spotted along the TLC plate along with tablet mixtures A, B and C. The
solution tablet mixtures were the same as the ones used for HPLC. Method 1 involved
using methanol as the mobile phase. Method 2 was gradually adding acetic acid to
increase the polarity ofthe mobile phase. The final method, method 3, was dissolving
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quinine and chloroquine, separately, in methanol and also using methanol as a mobile
phase.

Irby 14

Results and Discussion

HPLC
The initial information obtained from HPLC was the calibration curves for
quinine, mefloquine, and chloroquine which are shown in Figure 5.
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Figure 5. (A) quinine, (B) mefloquine, (C) chloroquine.

The chromatogram for each mixture standard showed two peaks that could be
characterized through their spectrum as either quinine and chloroquine while no
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discernible peak existed for mefloquine. An example chromatogram for standard four is
shown in Figure 6.

The retention time for quinine was usually around 5.5 minutes and was around 7.5
minutes for chloroquine. A cluster of peaks appeared from 13-15 minutes on each
chromatogram. These peaks were later determined to be caused by contaminants in the
mobile phase. Chromatograms with useful peaks were successfully obtained for the
tablet mixtures. An example chromatogram for tablet A is shown in Fi gure 7.

5.0

1 .0

1 .0

min

Figure 7. Tablet A.

As shown in Figure 7, a peak for quinine was produced around 5 .5 minutes and the
unknown contamination peaks were produced around 13-15 minutes.
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As shown in Figure 6, a peak for mefloquine was unable to be obtained and it
was thought to be due to low molar absorptivity coupled with low concentrations. The
original 1000 ppm stock solution of mefloquine was analyzed as well as a freshly made
1000 ppm solution. The data produced supported the idea that mefloquine is unstable in
solution as shown by the chromatograms in Figures 9 and 10.
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Figure 9. New mefloquine 1000 ppm solution.
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Figure 10. Old mefloquine 1000 ppm solution.

The new stock solution produces absorption of over 1750 mAU in Figure 9. This
chromatogram was produced by a stock solution that was under 2 weeks old. The
chromatogram in Figure 10 was produced by a stock solution that was several months
old and the peak for mefloquine has an absorbance of around 900 mAU. The only
variable between the two solutions is the time they remained on the shelf before being
analyzed using HPLC and the absorbencies prove that mefloquine is unstable in
solution and explains why mefloquine was unable to produce a peak in the original
standards.
Not only were the main active ingredients able to be distinguished using HPLC
but other false active ingredients such as acetaminophen and aspirin were separated. An
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example chromatogram of tablet H which contained acetaminophen as the false active
ingredient in place of quinine is shown in Figure 8.
_ 0nm ,4n'!llf1 .DO)

ri Acetaminophen

5.0

Figure 8. Tablet H.
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min

The retention times determine for acetaminophen and aspirin were 4 and 6.5 minutes
respectively. Using both the information for retention times and spectra, acetaminophen
and aspirin were distinguished from the actual anti-malarial active ingredients.
After the standards, the tablet mixtures were analyzed using HPLC as well. The
resulting concentrations are shown in Table 2.
Tablet

Active Ingredient

A
B
C
D
E
F
G
H
I

Quinine
Chloroquine
Mefloquine
None (Blank mixture)
Quinine
Chloroquine
Aspirin
Acetaminophen
Aspirin, Quinine

Experimental
Amount (ppm)
62
11
12
0.0

13
NQ*
N Q*
NQ*
NQ*, 21

Expected
Amount (ppm)
80

13
2.0
0.0
4.7
7.2
7.7
7.8
5.4, 2.4

Table 2. Concentrations of active ingredients as determined through the use of HPLC.
*Not quantifiable
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Although some of the experimental data are comparable to the expected data, such as
the case for tablet A and B, most of the concentrations do not seem to coincide. This is
believed to be due in part to inadequate mixing of the tablet ingredients. Another
problem that could have taken place is that most of the inactive ingredients are
hydrophobic and when the tablet mixtures were being diluted, the hydrophobic
components could have caused the active ingredient to become separated from the
solution. This might also have happened because the active in gredients such as quinine,
chloroquine, and mefloquine did not dissolve into solution easily.

Fluorescence
In an effort to develop a quick, inexpensive method of analysis, fluorescence
was chosen because the molecules being studied fluoresce well due to their structural
rigidity. Fluorescence spectroscopy produces results faster than HPLC and it is
significantly cheaper. Fluorescence is cheaper because it does not require the constant
flow of mobile phase or expensive columns. Overall, it could be a helpful tool in
determining presence as well as concentrations of active ingredients.
It was found through the use of several solvents that a quenching effect occurred
due to pH. The final solvent that was determined to be most suitable for this research
was phosphoric acid, H3P0 4 .
It should be noted that the fluorescence data is preliminary and many of the
issues that arose during research were unable to be completely solved due to time
constraints.
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In order to determine the presence of quinine or chloroquine, excitation at 250
nm would be useful as shown in Figure 11.
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Figure 11. Emission spectrum for all three active ingredients with excitation at 250 nm.

Since the emission intensities for quinine and chloroquine are very different then it
would be possible to characterize those active ingredients using the 250 nm excitation
wavelength. It would not be feasible to verify the presence of mefloquine at this
excitation wavelength because its absorbance intensity could be mistaken for that of
quinine. However, if an unknown tablet was analyzed at this wavelength and
determined to not have chloroquine because the molecule was yielding high emission
intensity then it could be analyzed at another wavelength to determine whether the
tablet contains either quinine or mefloquine. The excitation wavelength that could be
useful to differentiate between quinine and mefloquine is 365 nm. The emission
spectrum shown for this excitation wavelength is in Figure 12.
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Figure 12. Emission spectrum for all three active ingredients with excitation at 365 nm.

As this spectrum shows, this wavelength would not be useful in verifying the presence
of chloroquine versus quinine however it is useful in distinguishing between quinine
and mefloquine. Mefloquine barely produces emission intensity at this excitation
wavelength. In conclusion, by exciting the sample at both of these wavelengths, it could
be possible to determine the active ingredient.
Once the active ingredient is verified, the concentration could be determined by
exciting the sample at a suitable wavelength and using the resulting intensity and a
calibration curve. Experiments were done to determine the best excitation and emission
wavelengths for each molecule. The emission wavelengths were scanned from 300 run
to 500 nm and were determined by changing the excitation wavelength at every 5 nm
interval from 250 nm to 400 nm. Chloroquine was found to have an emission peak at
370 nm and it produces the highest intensity when its excited at 280 run. Mefloquine
was characterized with an emission peak at 455 nm which was best excited at 250 run.
Quinine had similar data which was an emission peak at 450 that had its highest
intensity when it was excited at 250 nm. Since aspirin and acetaminophen are
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commonly added as false active ingredients, the emission and excitation data were
determined for those drugs as well. Aspirin had an emission peak at 350 nm which was
best produced by exciting the molecule at 290 nm. Acetaminophen had an emission
peak at 310 nm which _had the highest intensity when the molecule was excited at 4 25
nm. Because the data for aspirin and acetaminophen are unique, it would be useful in
determining whether a tablet was counterfeited by using either of these ingredients in
comparison to the three anti-malarial ingredients.
Although the process for producing qualitative and quantitative data from
fluorescence spectroscopy would take several steps, it would still be less costly and
faster than HPLC. This is because the same sample would be used during each step of
analysis and the only adjustments would be on the instrument while the sample
remained in the cuvette.

UV-Vis
The UV -Vis spectrometer was primarily used to characterize the molecules on a
spectrum. It was used to obtain what wavelengths at which the molecules absorbed the
highest. The spectrum including all three molecules is shown in Figure 13.

Irby 22

-Chloroquine
-Quinine

4.5

Mefloquine

4
3.5

s
:::5.
8

;

.0
,:..

o
"'

3

2.5

2 .
1.5

.0

0

-0.5 190

215

240

265

290

315

340

365

Wavelength (nm)

Figure 13. UV spectra for the three active ingredients.

TLC
TLC was studied to verify whether this would be a useful method due to its
inexpensiveness and ability to rapidly produce results. The results for the three methods
used for TLC are shown in Figure 14.

Figure 14. A: TLC plate using method I; B: TLC plate using method 2; C, D: TLC plates
using method 3.

Method 1, which used methanol as the mobile phase, was unable to move the
spots of standards and tablet solutions. Method 2, which added acetic acid to methanol
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to create a more polar mobile phase, was also unable to move any spots as shown in
component B of Figure 14. Method 3 which consisted of dissolving a generic amount of
active ingredient into methanol and also using methanol as the mobile phase was able
to move the spots of standards and tablets. TLC is not useful when concentrations of
active ingredients are low because the spots of tablet mixtures did not fluoresce as well
as the stock solutions and sometimes not at all.
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Conclusions and Future Work
Due to the prevalence of counterfeit pharmaceuticals and the danger
they present to human health, it is important for scientists to develop useful methods of
detection for commonly counterfeited active ingredients in pharmaceuticals. The
research done has found that HPLC and fluorescence spectroscopy were effective in
producing qualitative and quantitative data about quinine, mefloquine, and
choloroquine.
In the future, the issues encountered during this research should be studied
further. Since the data for the tablet mixtures from HPLC did not coincide with the
expected values, it would be beneficial to de_velop an efficient method of blending and
dissolving the tablets. It was determined that mefloquine is instable in solution so
solution stability tests should be done. Since fluorescence proved to be a useful tool in
detecting the presence and concentration of the active ingredients then the tablets
should be analyzed using this instrument.
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